General MedicationsTOPICALGeneric
INGENOL MEBUTATE
INGENOL MEBUTATE
Standard Dose
0.015%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview INGENOL MEBUTATE is listed in Drugs@FDA under application 209018 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient INGENOL MEBUTATE Form and strength GEL;TOPICAL - 0.015% Sponsor PADAGIS ISRAEL Submission history Latest submission status date: 2021-03-19 00:00:00.
Structured Monograph
Clinical summary
Approval overview INGENOL MEBUTATE is listed in Drugs@FDA under application 209018 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient INGENOL MEBUTATE Form and strength GEL;TOPICAL - 0.015% Sponsor PADAGIS ISRAEL Submission history Latest submission status date: 2021-03-19 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.